病原治疗

  • 网络Pathogenic treatment;Target the pathogen;etiological treatment
病原治疗病原治疗
  1. 结论:AMB联合5-FC治疗新型隐球菌性脑膜炎时对外周血象的影响主要为贫血,外周血象的变化不是需要中断病原治疗的主要因素。

    CONCLUSION : The influence on peripheral blood figure from AMB combined with 5 FC in the treatment of the patients with cryptococcus meningitis is anaemia . The change of peripheral blood figure is not the main reason to stop treating .

  2. 隐球菌性脑膜炎病原治疗的护理

    Nursing Care of Pathogenic Treatment for Cryptococcal Meningitis

  3. 方法对30例男性不育症病人在病原治疗的基础上加用复合蛋白锌治疗4个月。

    Methods Thirty MS patients were given multiprotein-zinc in addition to pathogen-specific treatment for four months .

  4. 详细论述病原治疗、微生态制剂治疗、支持疗法、疫苗研究和应用等治疗方法及其作用机制、治疗特点;

    The pathogen treatment , probiotics , supportive therapy , research and application of vaccine and so on , are discussed in detail , and their mechanisms and the methods for treatment are analyzed .

  5. 肺部感染致病原特点及治疗策略

    Therapeutic Strategy Treatment and Characteristics of Algogen Pathogeny in Pulmonary Infection

  6. 66例肺心病下呼吸道感染病原菌与治疗观察

    Cor Pulmonale Caused Lower Respiratory Tract Infection and Treatment in 66 Patients

  7. 外眼细菌性感染的病原学及治疗(附200例临床分析)

    Etiology and treatment of bacterial infection of external eye ( report of 200 cases )

  8. 甲鱼暴发性传染病的病原分离及治疗试验

    Pathogen Isolation and Identification and Treatment Trial of Infectious " Soft shelled " Disease in Turtles

  9. 双重加工模型对抑郁认知易感性的评估、病原学和治疗提出了新的看法。

    Clinical Observation of Paroxetine in the Treatment of Patients with Pharyngeal Paraesthesia in Depression and Anxiety ;

  10. 目的探讨医院ICU内发生呼吸机相关肺炎(VAP)的临床病原学特点和治疗效果。

    Objective To disus the clinical pathogenic characteristic and therapy of ventilator associated pneumonia ( VAP ) in ICU .

  11. 目的了解导管相关性败血症(CRS)临床和病原学特点及治疗。

    OBJECTIVE To investigate the clinical and etiologic characteristics and treatment of central venous catheter-related ( sepsis ) .

  12. 目的了解呼吸机相关性肺炎(VAP)的危险因素、病原菌种类、治疗及预后。

    Objective To identify the risk factors , pathogens , treatment and prognosis n patients with ventilator-associated pneumonia ( VAP ) .

  13. 产ESBLs大肠杆菌是医院感染的重要病原菌之一,治疗一般均首选碳青霉烯类抗生素,选择性压力较大,且易诱发真菌等二重感染。

    Coli producing ESBLs is one of the most important pathogens of nosocomial infection . Carbopenems antibiotics are the first choice of therapy , but the selective pressure is high , and easy to induce secondary infection of fungi and so on .

  14. 细菌性重症肺炎患儿的病原菌分析及治疗对策

    The pathogenic analysis and therapy of children with severe bacteria pneumonia

  15. 婴幼儿轮状病毒肠炎48例病原学检测及治疗

    Pathogenic Examination and Therapy for 48 Cases of Infant Rotavirus Enteritis

  16. 桑花叶病病原及化学药剂治疗的研究

    Studies on Pathogenic Virus of Mulberry Mosaic Disease and Its Control with Chemotherapy

  17. 胜利油田小儿肺炎病原学检测及治疗效果分析

    Analysis of Detection and Therapeutic Effects in Children with Pneumonia Pathogen Shengli Oilfield

  18. 267例性病患者前列腺液病原学检测及治疗观察

    Etiological Detection of Prostatic Fluid in 267 Patients with Venereal Diseases and the Related Treatment

  19. 老年肺炎的危险因素与病原学特点及其治疗分析

    Analysis of risk factors and feature of pathogens and clinical treatment to the old pneumonia patients

  20. 早期作出病原学诊断是治疗肾移植术后肺部感染的关键。

    An early etiological diagnosis is necessary for the treatment of pulmonary infection after renal transplant .

  21. 缺血性脑血管病自由基损伤病原学及抗氧化治疗研究进展

    Advances in the Study of Free Radical-caused Injury Etiology and Antioxidation Treatment in Ischemic Cerebrovascular Disease

  22. 方法总结了1990~2005年间的38例腹膜后间隙化脓性感染的病例的临床资料,并进行发病原因、病原菌分布和治疗情况的分析。

    Methods The clinical data of 38 cases of retroperitoneal abscess from 1990 to 2005 were reviewed by evidence-based analysis .

  23. 结论在临床诊治实践中,皮肤海鱼分枝杆菌感染的诊断较为困难,需要综合病史、皮损、组织病理、病原学检查以及治疗反应来综合判断。

    Conclusions In clinical practice , the diagnosis of M.marinum skin infection is difficult and made on the basis of history , lesion , histologic feature , microbiology , and response to treatment .

  24. 方法采用回顾性分析法对47例药物性肝炎住院患者的用药史、临床表现、肝功能检查、病原学标志以及治疗转归做出综合分析。

    Methods 47 cases with drug-induced liver damage admitted to our hospital from 1995 to 2004.They were reviewed with respect to their drug history , clinical symptom and signs , liver function test , serum viral markers and therapeutic effect .